Azathioprine production begins with the synthesis of 6-mercaptopurine. This involves careful reaction control and purification steps to ensure high purity. Subsequent conversion to azathioprine requires precise conditions, meticulously monitored for optimal yield and minimal impurity formation. This includes rigorous temperature and pH control throughout the process.
Crystallisation and filtration are critical for isolating the azathioprine, removing residual reactants and by-products. Drying is performed under controlled conditions to avoid degradation. The entire process is validated, ensuring consistent product quality batch after batch.
Quality control involves multiple stages. High-performance liquid chromatography (HPLC) measures purity and identifies potential contaminants. Spectroscopic techniques verify the azathioprine structure and quantify any impurities present. Potency assays ensure the product meets the required pharmacological activity. Microbial testing confirms the absence of harmful bacteria and fungi. Particle size analysis ensures consistent drug dissolution.
Packaging and storage conditions are carefully defined to maintain product stability and prevent degradation. Stringent documentation tracks every step, ensuring traceability and compliance with regulatory requirements, such as GMP (Good Manufacturing Practices).
Regular audits and inspections ensure adherence to established quality standards. Continuous improvement initiatives refine the manufacturing process and enhance product quality over time. This commitment to rigorous quality control ensures patient safety and efficacy.
